Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)

This study has been completed.
Hoffmann-La Roche
Information provided by (Responsible Party):
Chugai Pharmaceutical Identifier:
First received: September 9, 2009
Last updated: October 1, 2014
Last verified: October 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2014
  Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)